Showing posts with label Negative-strand RNA Viruses. Show all posts
Showing posts with label Negative-strand RNA Viruses. Show all posts

Saturday, 5 October 2024

Outbreak of Marburg Virus reported in Rwanda.

On 27 September 2024 the  Rwanda Ministry of Health confirmed that an outbreak of Marburg Virus Disease was present in the country, following the detection of the Virus in the blood of two patients by real-time reverse transcription polymerase chain reaction analysis at the National Reference Laboratory of the Rwanda Biomedical Center, according to a press release issued by the World Health Organization on 30 September 2024.

As of 29 September 2024, 26 cases of the disease have been reported in seven of the country's thirty districts (Gasabo, Gatsibo, Kamonyi, Kicukiro, Nyagatare, Nyarugenge and Rubavu), with eight people having died of the disease, a case fatality rate of 31%. The majority of the patients are healthcare workers from two health facilities in Kigali; this is not uncommon with outbreaks of the Marburg and Ebola viruses, with the highly transmittable nature of these diseases often resulting in aa high mortality rate in healthcare workers around the initial locus of the outbreak.

Contract tracing has led to the screening of about 300 contacts of diagnosed patients, one of whom had travelled to Belgium, with all found to be healthy and not a threat to public health. The initial source of the outbreak is still under investigation.

Marburg Virus Disease is a haemorrhagic fever, similar to the closely related Ebola Virus Disease. Both are caused by single-strand negative-sense RNA viruses of the Filoviridae family. Both are easily spread though contact with bodily fluids, and can also spread by contaminated clothing and bedding. 

Negative stained transmission electron micrograph of a number of filamentous Marburg Virions, which had been cultured on Vero cell cultures, and purified on sucrose, rate-zonal gradients. Erskine Palmer/Russell Regnery/Centers for Disease Control and Prevention/Wikimedia Commons.

Marburg Virus has an incubation period of between two and 21 days, manifesting at first as a high fever, combined with a severe headache and a strong sense of malaise. This is typically followed after about three days by severe abdominal pains, with watery diarrhoea and vomiting. In severe cases the disease develops to a haemorrhagic stage after five-to-seven days, manifesting as bleeding from some or all bodily orifices. This typically leads to death on day eight or nine, from severe blood loss and shock. There is currently no treatment or vaccine available for Marburg Virus, although a number of teams are working on trying to develop vaccines. 

Previous outbreaks of Marburg Virus have been reported in Rwanda, as well as the neighbouring Democratic Republic of Congo and Tanzania. The Virus has also been reported in a number of other African countries, including Angola, Equatorial Guinea, Ghana, Guinea, Kenya, and South Africa. The most recent outbreaks occurred in January 2023, with unrelated epidemics in Tanzania and Equatorial Guinea. 

The high rate of infection of healthcare workers seen in Marburg Virus is particularly alarming, as this tends to weaken communities ability to resist the Virus. The Virus can spread quickly in healthcare settings, infecting people whose immune systems are already stressed by other conditions, and creating aa reserve which can feed infections in the wider community. This makes it important to screen all people potentially infected with the disease as quickly as possible, and to arrange for patients to be treated in isolation, as well as quickly tracing all known contacts of any cases, and screening them for infection too.

Marburg Virus is a zoonotic infection (disease transferred from Animals to Humans), with a wild-reserve of the Virus known to be present in Egyptian Fruit Bats, Rousettus aegyptiacus, which are found across much of Africa, the Mediterranean region, the Middle East, and South Asia. These Bats form large colonies in caves or sometimes mines. They are frugivores, and can be major pests of farmed fruits, bringing them into conflict with Humans, and are sometimes hunted for food, all of which create potential avenues for the Marburg Virus to pass from a Bat host to a Human one.

A colony of Egyptian Rousette Bats, Rousettus aegyptiacus. Giovanni Mari/Flikr/iNaturalist.

See also...

Tuesday, 3 September 2024

Outbreak of Chandipura Virus causes at least 82 deaths in India.

Between 1 June and 15 August 2024, the Indian Ministry of Health and Family Welfare recorded 245 cases of suspected Chandipura Virus infection in Gujarat and Rajasthan states, with 45 districts affected and 82 known deaths, a case fatality rate of 33%, according to a press release issued by the World Health Organization on 23 August 2024. Sixty four of the cases have been confirmed as Chandipura Virus by either immunoglobulin M enzyme-linked immunosorbent assay or reverse transcription polymerase chain reaction, sixty one of these in Gujarat and three in Rajasthan. The number of new cases being reported has been declining since 19 July 2024.

Chandipura Virus, or Chandipura vesiculovirus, is endemic to western, central, and southern India, with sporadic outbreaks occurring across this region,  typically during the monsoon season. In 2023 an outbreak of the Virus in Andhra Pradesh led to 183 deaths among 329 reported cases, a case fatality rate of 55.6%. Other recent outbreaks have led to case fatality rates of between 56 and 75%. In Gujarat there appears to be a spike in cases every four-to-five years. 

Chandipura vesiculovirus is a negative-sense single-stranded RNA Virus in the family Rhabdoviridae. Like many Viruses in this family, it is a zoonotic disease which can be spread by a number of Arthropod vectors, including Sandflies, Mosquitoes, and Ticks, although its main vector appears to be the Sandfly, Phlebotomus papatasi. Notably, although Human infections with Chandipura vesiculovirus have been reported only from India, the Sandfly, Phlebotomus papatasi, has a much wider distribution, and the Virus has been extracted from Sandflies in Senegal, as well as a range of Mammals in Senegal, Nigeria, Bhutan, and Nepal, suggesting a much wider, undetected, range.

Transmission electron micrographs of primary Chandipura Virus isolates from culture. Rao et al. (2004).

Chandipura Virus infection can lead to the development of a febrile disease, predominantly in children under 15, which can lead rapidly to convulsions, coma, and in the worst cases, death. In children, where fatality occurs, it typically happens within 48-72 hours of the first symptoms being detected.

The Indian Ministry of Health and Social Welfare has deployed specialist teams to Gujarat State to help implement control measures, including fumigating dwellings with insecticide to control the vectors of the disease and an education campaign aimed at raising awareness of the Virus, symptoms, and preventive measures.

See also...

Friday, 26 January 2024

The epidemiology of the 2020 Ebola outbreak in Équateur Province, Democratic Republic of the Congo.

On 1 June 2020 medical authorities in Équateur Province, Democratic Republic of the Congo, reported an outbreak of Ebolavirus Disease in Mbandaka, the capital of Équateur Province. This was the eleventh reported outbreak of an Ebola-type disease in the Democratic Republic of the Congo, and was close to the location of a previous outbreak in the Bikoro health zone of Équateur Province, which occurred in 2018. The Democratic Republic of the Congo suffered fifteen outbreaks of Ebola-type diseases between 1 September 1976 and 22 August 2022, with the 2020 Équateur Province outbreak being the eleventh of these. The majority of these were caused by the Ebolavirus, and occurred in the north of the country, although one, in Haut-Uélé Province in 2012, was caused by the Bundibugyo Virus.

Ebolavirus has not been found in Bats in the Democratic Republic of the Congo, but the closely related Marburg Virus has, and Bats with antibodies to Ebolavirus have been found in Nord Kivu Province and Équateur provinces, as well as in the neighbouring Republic of Congo. Outbreaks of Ebola have been associated with the handling of Chimpanzees and Gorillas in the Republic of Congo and Gabon, and Ape populations have been known suffer dramatic declines at the same time as local Human populations have suffered outbreaks of Ebola-type diseases. Furthermore, as with other Filoviruses, Ebolavirus can persist in the system of survivors after they have apparently recovered, and cause new infections via sexual transmission or other exchange of bodily fluids. Before it became possible to identify Ebolaviruses by rapid genetic sequencing, it was impossible to tell whether outbreaks of the disease were caused by new infections from zoonotic sources (i.e. Animals) or transmission from apparently heathy survivors.

In a paper published in the journal The Lancet Microbe on 23 January 2024, a team of scientists led by Eddy Kinganda-Lusamaki of the Pathogen Genomics Laboratory at the Institut National de Recherche Biomédicale in Kinshasa, the Faculté de Médecine at the Université de Kinshasa, and the Institut de Recherche pour le Développement at the University of Montpellier, present the results of an assessment of the epidemiological and genetic properties of the 2020 Équateur Province Ebola outbreak.

The 2020 Équateur Province outbreak was the Democratic Republic of the Congo's eleventh Ebola outbreak, and started while the tenth outbreak, in North Kivu Province, was still ongoing. This led to suspicions that the two events were related, with the Équateur Province potentially being caused by an infected person travelling from North Kivu. Kinganda-Lusamaki et al. were able to demonstrate that this was not the case, with the two outbreaks being caused by different strains of Ebolavirus, and the Équateur Province outbreak having a zoonotic origin.

Ebolavirus outbreaks in the Democratic Republic of the Congo, 1976–2022. (A) The distribution of Ebolavirus disease outbreaks in the Democratic Republic of the Congo. Coloured circles identify locations of previous outbreaks and the size of circles represents the number of positive Human cases. The map shows the affected 2020 health zones (orange and purple shading) and sites of the 2018 Équateur outbreak (orange shading). The red star indicates the location of the Kinshasa diagnostic laboratory during the Équateur Province 2020 outbreak. (B) The locations and prevalence of Ebolavirus disease cases during the 2020 Ebola virus disease outbreak in the Équateur Province. The red stars indicate the location of the diagnostic and field laboratories during the Équateur Province 2020 outbreak (Mbandaka, Ingende, Itipo, Bikoro, and Bolomba). Kinganda-Lusamaki et al. (2024).

Blood samples from live patients with suspected Ebola and oral swabs from deceased patients thought to have died of Ebola were tested for signs of the Virus. Unlike in previous outbreaks, the presence of a fever was not required for patients to be included in the suspected group, since it has been demonstrated that not all people infected with Ebolavirus develop a fever.

Between 19 May and 16 September 2020, 130 probable cases of Ebola were reported in., 119 of which were confirmed by laboratory analysis. Of the 130 suspected cases, 55 died, a case fatality rate of 42%. Cases were reported in thirteen health zones, Bikoro, Bolenge, Bolomba, Bomongo, Iboko, Ingende, Lilanga Bobangi, Lolanga Mampoko, Lotumbe, Mkanza, Mbandaka, Monieka, and Wangata. The epidemic declined rapidly after August, with the last case being reported on 12 September. Thhe highest number of infections was among men in the 45 or older age bracket, while the least affected group were children aged 5-14. This is surprising, as Équateur Province has a young population, with many more children than older men. This was particularly true in the early stages of the epidemic, with no individuals of 15 or younger affected in May or June, while several children were infected between July and September. The date of the first onset of symptoms was identified for all cases. Forty seven infected persons visited more one health clinic after the onset of symptoms, with three individuals visiting four separate health clinics. The earliest identified case was a 37-year-old woman identified as a housewife, residing in the Mbandaka health zone, who had no contact with any known earlier case, but who was known to have consumed wild Bat meat, strongly suggesting a zoonitic origin for the epidemic.

Demographics of Ebolavirus Disease cases during the 2020 Équateur Province outbreak (A) Epidemiological curve of confirmed and probable Ebolavirus Disease cases over time. (B) Age distribution of confirmed and probable Ebolavirus Disease cases by gender (the black horizontal bars represent the 2020 Democratic Republic of the Congo known age and gender population distribution from the World Health Organization). (C) Temporal age distribution of individuals with Ebolavirus Disease. (D) Distribution of patients with Ebolavirus Disease who visited multiple health-care facilities after symptoms onset. Kinganda-Lusamaki et al. (2024).

Three of the people infected during the epidemic were healthcare workers, and one a traditional healer. Two of these died. Thirty seven of the infected were described as farmers, fishers, or hunters, 25 as housewives, and seven as businesspeople. Ninety four of the infected people are known to have had contact with another known case before becoming infected. Nine reported having contact with an unidentified person who they thought might be infected, 23 had no known link to another case, and four reported contact with Animals which may have passed on the infection.

Nineteen of the infected are believed to have contracted the Virus from a member of their household, twenty from another member of their community, twelve people are thought to have contracted the Virus at a funeral. Twenty seven patients reported multiple potential contact sources, in 44 cases the route of exposure was unknown.

While it was not possible to obtain specimens from all patients, Kinganda-Lusamaki et al. were able to obtain 188 specimens from 122 of the patients, from which they were able to sequence 87 viral genomes. This led to the discovery that there were in fact two separate variants of the Virus circulating during the epidemic, with 83 of the genomes belonging to the Mbandaka variant of the Virus and three belonging to the Tumba variant; a partial sequence (defined as a sequence where less than 70% of the Viruses DNA was recovered) obtained from another patient was also identified as belonging to the Tumba variant. All of the Mbandaka variant cases were calculated to have descended from a last common ancestor which probably existed in a non-Human host in January 2020, with two separate instances of the Virus jumping to Human hosts and then spreading within the community. The first known example of the Tumba variant in the 2020 outbreak was a nineteen-year-old man who visited two separate healthcare clinics before being diagnosed. This patient had no-known contact with any earlier patient, nor had he consumed bushmeat or had contact with any wild or domestic Animals. All three subsequent cases had had contact with this initial case. The previous outbreak of Ebola in Équateur Province in 2018 was also the Tumba variant of the Virus, although it was impossible to determine whether the new outbreak was due to a persistent infection from the earlier epidemic.

By using patient-generated data, Kinganda-Lusamaki et al. were able to generate a history of the 2020 Ebolavirus outbreak in Équateur Province, Democratic Republic of the Congo, which included genetic data, records of health centre visits, dates of infection, identification of the Virus, isolation of patients, and deaths. This enabled them to plot chains of infection, with nineteen chains of infection being determined before generic data was incorporated into the study, and eighteen of these subsequently being stitched together with genetic data to form the Mbandaka variant tree. Twenty of the patients had no determined route of infection, with eleven of these also subsequently added to the Mbandaka variant tree from genetic data; genetic data was not available from the remaining nine patients. Three individuals reported that believing they had contracted the Virus from contact with Animals, but were demonstrated to be part  of the Human-to-Human chain of Mbandaka variant infection. Two individuals were identified from samples taken when they visited healthcare clinics for reasons unrelated to Ebolavirus; both went on to develop symptoms of the disease.

Kinganda-Lusamaki et al. were able to develop an extensive overview of the 2020 Ebolavirus outbreak in Équateur Province, but caution that this data is still probably incomplete, with cases for which the infection routes were unknown or only probable, making it likely that there were other, unidentified cases within the community. A similar pattern was observed in the concurrent epidemic in North Kivu Province. The outbreak appeared to start with an individual who consumed Bat meat, and was of a newly identified strain of the Ebolavirus, identified as the Mbandaka variant. A minority of the cases belonged to a second strain, the Tumba variant, which caused an epidemic of the disease in 2018, and appeared to re-emerge from a survivor in 2020. The Équateur Province outbreak was found to be unrelated to the concurrent North Kivu Province epidemic, contrary to expectations. Their hope is that by utilising both social and genetic data to understand the transmission of the Virus their study will enable healthcare workers to be able to better manage future outbreaks of Ebolavirus.

Kinganda-Lusamaki et al. identified several different routes of Ebolavirus infection during the 2020 outbreak, including zoonotic transmission from Animals, person-to-person infection due to close contact with infected individuals, and the re-emergence of the Virus from a persistent infection. The ability of the Virus to re-emerge as a persistent infection from apparently healthy individuals after quite long intervals has proven to be a problem in other Ebolavirus outbreaks elsewhere in the Democratic Republic of the Congo, as well as in Guinea. This can be differentiated from fresh zoonotic infections by genetic testing (the persistent infection will be genetically close to the previous outbreak, whereas a fresh zoonotic infection is likely to have a novel genome, forming their own distinct clade of infections.

Research around the 2014 Ebolavirus outbreak in Guinea, Sierra Leone, and Liberia demonstrated the importance of educating survivors of the disease of the potential dangers of transmitting the disease after all symptoms have passed, something which Kinganda-Lusamaki et al.'s emphasise.

In the 2020 Équateur Province it took an average of six days between the onset of symptoms and patients being isolated within medical facilities (which was quite often longer than the patient lived), as a consequence, many patients visited multiple healthcare facilities, increasing the number of other people they came into contact with. Based upon this, Kinganda-Lusamaki et al. strongly recommend that in future outbreaks a system of rapid testing is introduced as quickly as possible. They note that an enhanced viral haemorrhagic fever surveillance programme has helped the country to respond rapidly to several outbreaks of different haemorrhagic diseases (including Marburg Virus Disease, Crimean-Congo haemorrhagic fever, and Rift Valley fever), resulting in the severity and duration of the outbreaks being reduced. A similar system would enable the Democratic Republic of the Congo to respond in the same way.

During the last three weeks of the 2020 Équateur Province outbreak, cases were limted to six healthcare districts, falling to two in the last two weeks. Eight of the thirteen new cases reported in the last three weeks were children under fourteen years of age, possibly suggesting that the majority of older people in the area by this time were producing antibodies to the disease, either as a result of prior exposure or vaccination. During the outbreak the rVSVΔG-ZEBOV-GP vaccine was administered to all known contacts of patients who were more than six months old, as part of a  ring vaccination strategy. Unfortunately, record keeping was imperfect, and it is unclear if the reported cases in the last few weeks had been vaccinated, or whether they had been in contact with unvaccinated people. During the North Kivu outbreak the same vaccine was found not to offer absolute protection from infection, but infected people were found to suffer fewer symptoms, recovered more quickly, and were less likely to die. Vaccinated people were found to be producing antibodies to the Virus six months after they were vaccinated. It is unclear whether natural immunity, or the immunity offered by vaccination, wanes over time for Ebolavirus

See also...

Tuesday, 13 June 2023

Tanzania and Equatorial Guinea declare end to Marburg Virus outbreaks.

On 2 June 2023, the Ministry of Health of the United Republic of Tanzania declared the end of its first documented outbreak of Marburg Virus Disease, according to a press release issued by the World Health Organization on 2 June 2023. Between 21 March and 31 May, a total of nine cases (eight laboratory-confirmed and one probable) were reported in Tanzania. All cases were reported from Bukoba district, Kagera region. A total of six deaths (a case fatality ratio of 67%) were reported during the outbreak. The declaration was made 42 days (twice the maximum incubation period for Marburg virus infection) after the last possible exposure to an Marburg Virus Disease probable or confirmed case, in accordance with World Health Organization recommendations.

On 8 June 2023, after two consecutive incubation periods (42 days) without a new confirmed case reported, the Ministry of Health of Equatorial Guinea declared the end of the Marburg Virus Disease outbreak, again as per the World Health Organization recommendations, according to a second press release, issued by the World Health Organization on 9 June 2023. A total of 17 confirmed and 23 probable cases were reported from five districts in four provinces; 12 of the 17 confirmed cases died and all the probable cases were reported deaths.  

The World Health Organization encourages countries to maintain most response activities for three months after the outbreak ends. This is to make sure that if the disease re-emerges, health authorities would be able to detect it immediately, prevent the disease from spreading again, and ultimately save lives.

On 21 March 2023, the Ministry of Health of the United Republic of Tanzania officially declared the first Marburg Virus Disease outbreak in the country. Between 21 March and 31 May, a total of nine cases, including eight laboratory-confirmed cases and one probable (the index case), were reported. The last confirmed case was reported on 11 April 2023 and the date of sample collection of the second negative polymerase chain reaction test was on 19 April 2023. All cases were reported from Bukoba District in Kagera Region, in the north of the country.

Map of district reporting Marburg Virus Disease confirmed and probable cases in the United Republic of Tanzania, as of 31 May 2023. World Health Organization.

In Tanzania cases ranged in age from 1 to 59 years old (median 35 years old), with males being the most affected (six cases, or 67% of the total). Six cases were close relatives of the index case, and two were healthcare workers who provided medical care to the patients.

Distribution of Marburg Virus Disease cases (confirmed and probable) by date of symptom onset in the United Republic of Tanzania, as of 31 May 2023. World Health Organization.

From the outbreak declaration until 7 June 2023, 17 confirmed and 23 probable cases of Marburg Virus Disease were reported in the continental region of Equatorial Guinea. Twelve of the confirmed cases died and all the probable cases were reported deaths (the case fatality ratio among confirmed cases is 75%, excluding one confirmed case with an unknown outcome).

The last confirmed case admitted to a Marburg treatment centre in Bata District in Litoral Province was discharged on 26 April, after two consecutive negative polymerase chain reaction tests for Marburg Virus Disease. On 8 June 2023, after two consecutive incubation periods (42 days) without a new confirmed case reported, the Ministry of Health of Equatorial Guinea declared the end of the outbreak.

Confirmed or probable cases were reported in five districts (Bata, Ebebiyin, Evinayong, Nsok Nsomo and Nsork) in four of the country’s eight provinces (Centro Sur, Kié-Ntem, Litoral and Wele-Nzas). 

Map of districts reporting Marburg Virus Disease confirmed and probable cases during the outbreak, Equatorial Guinea. World Health Organization.

Five cases (31%) were identified among healthcare workers, of whom two died (a case fatality ratio of 40% among health care workers). Four patients recovered and were enrolled in a survivor care programme to receive psychosocial and other post-recovery support.

Marburg Virus Disease cases by week of symptoms onset* and case classification, Equatorial Guinea, as of 7 June 2023. World Health Organization.

Marburg Virus is a negative-strand RNA Virus belonging to the Family Filoviridae, which also includes the Ebola Virus. The Virus spreads between people via direct contact through broken skin or mucous membranes with the blood, secretions, organs or other bodily fluids of infected people, and with surfaces and materials such as bedding, and clothing contaminated with these fluids, although the natural reservoir of the Virus is thought to be Egyptian Fruit Bats, Rousettus aegyptiacus, with outbreaks often starting when people come into contact with colonies of these Bats in caves or mines. Healthcare workers have previously been infected while treating suspected or confirmed Marburg Virus Disease patients. Burial ceremonies that involve direct contact with the body of the deceased can also contribute to the transmission of Marburg Virus.

Negative stained transmission electron micrograph of a number of filamentous Marburg Virions, which had been cultured on Vero cell cultures, and purified on sucrose, rate-zonal gradients. Erskine Palmer/Russell Regnery/Centers for Disease Control and Prevention/Wikimedia Commons.

The incubation period varies from two to 21 days. Illness caused by Marburg Virus begins abruptly, with high fever, severe headache, and severe malaise. Severe haemorrhagic manifestations may appear between five and seven days from symptom onset, although not all cases have haemorrhagic signs, and fatal cases usually have some form of bleeding, often from multiple areas.

Early supportive care – rehydration with oral or intravenous fluids – and treatment of specific symptoms and co-infections can improve survival. A range of potential treatments are being evaluated, including blood products, immune therapies, and drug therapies.  

See also...


Follow Sciency Thoughts on Facebook.

Follow Sciency Thoughts on Twitter


Sunday, 21 February 2021

Outbreak of Rift Valley Fever reported in Kenya.

The World Health Organization has reported an outbreak of Rift Valley Fever in Kenya, in Humans in Isiolo and Mandera counties and in Animals in Isiolo, Mandera, Murang’a and Garissa counties. As of 4 February 2021, there were a total of 32 human cases (14 confirmed positive), and 11 deaths (a case-fatality ratio of 34 %). 

The event is believed to have started on 19 November 2020, with deaths among herders presenting with symptoms of fever, headache, general malaise with or without nausea, epistaxis/hematemesis, and abdominal pain/diarrhoea reported to the County Department of Health in Isiolo. The first Human case was reported in late November 2020 from Sericho ward in Garbatulla Subcounty. Deaths have been reported in Gafarsa and Erisaboru within Garbatulla subcounty as well Korbesa in Merti subcounty. On 16 December, Rift Valley Fever was confirmed by polymerase chain reaction at the National Virology Laboratory of the Kenya Medical Research Institute. As of 4 February 2021, a total of 22 Human cases had been reported (12 confirmed positive), and 10 deaths (three confirmed positive). Most cases were from Garbatulla subcounty, with the majority being herders, male, and aged 13 to 70 years old.

Sheep and goats were also reported sick on 19 November 2020 in Sericho subcounty, which is mainly pastoral. The communities in this area live in villages and livestock are grazed in communal grazing areas. Animal samples tested immunoglobulin M and real time polymerase chain reaction positive for Rift Valley Fever at the Central Veterinary Laboratory in Kabete and the Regional Veterinary Investigation Laboratory in Garissa. The event was officially confirmed on 7 January 2021 and reported to the World Organisation for Animal Health on 15 January 2021 and later on 22 and 29 January 2021. As of 27 January, a total of 20 livestock samples (19 Sheep and 1 Camel) had tested positive for Rift Valley Fever by immunoglobulin M-capture enzyme-linked immunosorbent assay and real-time polymerase chain reaction.

A patient from Kalmalab village, Mandera North subcounty fell ill after he was involved in the slaughter of four sick Camels. He was evacuated to a Nairobi hospital with haemorrhagic symptoms on 18 January. He was later admitted to the Intensive Care Unit with multiple organ failure. Rift Valley Fever was confirmed on 21 January at the National Virology Laboratory. He died on 22 January 2021. As of 4 February 2021, a total of 10 cases (2 confirmed Rift Valley Fever positive), including 1 death had been reported from Mandera North sub county.

Kalmalab village borders the river Dawa which broke its banks following rains in the Ethiopian highlands. The Rift Valley Fever outbreak may be associated with this flooding, as it increases the risk of Mosquito-borne zoonosis. Livestock samples have been submitted to the Central Veterinary Laboratory in Kabete for testing.

Livestock with Rift Valley Fever syndromes (including bleeding and abortions) were first reported on 29 December 2020 in Gatanga subcounty, Kihumbuini ward. The first Animal death was reported on 1 January 2021. Samples were collected from the same farm on 1 January and were confirmed Rift Valley Fever positive on 3 January at the Central Veterinary Laboratory in Kabete using enzyme-linked immunosorbent assay immunoglobulin G/immunoglobulin M testing. More suspected Animal cases have been reported in Ng’araria ward in Kandara subcounty. No Human cases have been confirmed, however suspected cases were traced and samples from affected households were collected on 25 January for testing at National Virology Laboratory. 

Samples from suspected livestock (Sheep and Goats) were collected from Masalani, Ijara Subcounty and Balambala, Balambala Subcountrym on 20 December 2020 for testing and were confirmed positive for Rift Valley Fever on 22 December using enzyme-linked immunosorbent assay immunoglobulin M testing. Field investigations are ongoing to determine the extent of the outbreak.

Surveillance in livestock was initiated after the detection of the Rift Valley Fever outbreak in Isiolo. Outbreaks among Animals were observed during this time period. In December 2020, results from the Central Veterinary Laboratory in Kabete taken from 120 livestock revealed 20 (19 Sheep out of which 10 died, and 1 Camel) positive Rift Valley Fever cases confirmed by enzyme-linked immunosorbent assay immunoglobulin M testing. Further laboratory analysis are ongoing in both Human and livestock samples.

Rift Valley Fever is a Viral zoonotic disease that primarily affects Animals but also has the capacity to infect Humans. Infection can cause severe disease in both Animals and Humans. The disease also results in significant economic losses due to death and abortion among Rift Valley Fever-infected livestock. 

The Rift Valley Fever Virus is a member of the Phlebovirus genus in the order Bunyavirales, of segmented negative-strand RNA Viruses, the group which also includes Hantavirus (Leprosy) and Lassa Virus (Lassa Fever). 

 
A Phlebovirus Viron. Michèle Bouloy in Tidona et al. (2002).

The Rift Valley Fever Virus was first identified in 1931 during an investigation into an epidemic among sheep on a farm in the Rift Valley of Kenya. Since then, outbreaks have been reported in sub-Saharan Africa. In 1977 an explosive outbreak was reported in Egypt, the Rift Valley Fever virus was introduced to Egypt via infected livestock trade along the Nile irrigation system. In 1997–98, a major outbreak occurred in Kenya, Somalia and Tanzania following El Niño event and extensive flooding. Following infected livestock trade from the horn of Africa, Rift Valley Fever spread in September 2000 to Saudi Arabia and Yemen, marking the first reported occurrence of the disease outside the African continent and raising concerns that it could extend to other parts of Asia and Europe.

The majority of Human infections result from direct or indirect contact with the blood or organs of infected animals. The Virus can be transmitted to humans through the handling of animal tissue during slaughtering or butchering, assisting with animal births, conducting veterinary procedures, or from the disposal of carcasses or fetuses. Certain occupational groups such as herders, farmers, slaughterhouse workers, and veterinarians are therefore at higher risk of infection.  

The Virus infects Humans through inoculation, for example via a wound from an infected knife or through contact with broken skin, or through inhalation of aerosols produced during the slaughter of infected Animals.  

There is some evidence that humans may become infected with Rift Valley Fever by ingesting the unpasteurised or uncooked milk of infected Animals. Human infections have also resulted from the bites of infected Mosquitoes, most commonly the Aedes and Culex Mosquitoes and the transmission of Rift Valley Fever Virus by hematophagous (blood-feeding) Flies is also possible. To date, no human-to-human transmission of Rift Valley Fever has been documented, and no transmission of Rift Valley Fever to health care workers has been reported when standard infection control precautions have been put in place. There has been no evidence of outbreaks of Rift Valley Fever in urban areas.

 
The ecological cycle for the Rift Valley Fever Virus. Mosquitoes are both a reservoir and vector for Rift Valley Fever Virus, which means that they can maintain Virus for life and transmit it to their offspring via eggs. After periods of heavy rainfall and flooding, an increased number of Rift Valley Fever Virus-infected Mosquitos may hatch and pass virus to People and Animals. Humans become infected through mosquito bites and through direct contact with infected animal blood or tissue. Direct contact can occur during slaughtering of infected Animals and veterinary procedures. No Human-to-Human transmission has been documented. Centers for Disease Control and Prevention.

The World Health Organisation is working closely with the Kenyan Ministry of Health via the local health cluster alongside the Food and Agriculture Organization and World Organisation for Animal Health in supporting the Rift Valley Fever outbreak investigation (determining extent of the outbreak, associated risk factors, vector surveillance, and ecology mapping), as well as the raining of health care workers, raising awareness via radio spots, printing and dissemination of information, education and communication materials, building capacity of the county laboratories to carry out tests for Rift Valley Fever and other diseases, as well as a  range of other activities.

See also...














Follow Sciency Thoughts on Facebook.

Follow Sciency Thoughts on Twitter.